NCT00109473View on ClinicalTrials.gov

Trial of Growth Hormone Therapy in Pediatric Crohn's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2009

Conditions

Crohn's Disease

Interventions

DRUG

growth hormone

Nutropin AQ 0.075mg/kg/day subcutaneously daily

DRUG

cortecosteroid

As prescribed by the referring gastroenterologist

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER